262 related articles for article (PubMed ID: 22800573)
1. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles.
Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS
J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573
[TBL] [Abstract][Full Text] [Related]
2. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
5. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
6. siRNA-chitosan complexes in poly(lactic-co-glycolic acid) nanoparticles for the silencing of aquaporin-1 in cancer cells.
Stigliano C; Aryal S; de Tullio MD; Nicchia GP; Pascazio G; Svelto M; Decuzzi P
Mol Pharm; 2013 Aug; 10(8):3186-94. PubMed ID: 23789777
[TBL] [Abstract][Full Text] [Related]
7. Self-assembled siRNA-PLGA conjugate micelles for gene silencing.
Lee SH; Mok H; Lee Y; Park TG
J Control Release; 2011 May; 152(1):152-8. PubMed ID: 21185893
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
[TBL] [Abstract][Full Text] [Related]
9. Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery.
Chen M; Gao S; Dong M; Song J; Yang C; Howard KA; Kjems J; Besenbacher F
ACS Nano; 2012 Jun; 6(6):4835-44. PubMed ID: 22621383
[TBL] [Abstract][Full Text] [Related]
10. siRNA delivery with chitosan nanoparticles: Molecular properties favoring efficient gene silencing.
Malmo J; Sørgård H; Vårum KM; Strand SP
J Control Release; 2012 Mar; 158(2):261-8. PubMed ID: 22119955
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of STAT3 expression in SKOV3 cells by biodegradable siRNA-PLGA/CSO conjugate micelles.
Zhao Y; Zheng C; Zhang L; Chen Y; Ye Y; Zhao M
Colloids Surf B Biointerfaces; 2015 Mar; 127():155-63. PubMed ID: 25677339
[TBL] [Abstract][Full Text] [Related]
12. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Katas H; Cevher E; Alpar HO
Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
[TBL] [Abstract][Full Text] [Related]
13. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.
Benfer M; Kissel T
Eur J Pharm Biopharm; 2012 Feb; 80(2):247-56. PubMed ID: 22085653
[TBL] [Abstract][Full Text] [Related]
14. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A
Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176
[TBL] [Abstract][Full Text] [Related]
15. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
[TBL] [Abstract][Full Text] [Related]
16. The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis.
Park JS; Yang HN; Jeon SY; Woo DG; Kim MS; Park KH
Biomaterials; 2012 Nov; 33(33):8600-12. PubMed ID: 22910222
[TBL] [Abstract][Full Text] [Related]
17. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H
J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303
[TBL] [Abstract][Full Text] [Related]
18. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
[TBL] [Abstract][Full Text] [Related]
19. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity.
Holzerny P; Ajdini B; Heusermann W; Bruno K; Schuleit M; Meinel L; Keller M
J Control Release; 2012 Jan; 157(2):297-304. PubMed ID: 21884740
[TBL] [Abstract][Full Text] [Related]
20. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
